Loading...
Colgate-Palmolive Company
CL•NYSE
Consumer DefensiveHousehold & Personal Products
$90.17
$-0.03(-0.03%)
Colgate-Palmolive Company (CL) Financial Performance & Statements
Review Colgate-Palmolive Company’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
3.31%
↑ 3.31%
Operating Income Growth
7.13%
↑ 7.13%
Net Income Growth
25.61%
↑ 25.61%
Operating Cash Flow Growth
9.67%
↑ 9.67%
Operating Margin
21.87%
↑ 21.87%
Gross Margin
60.72%
↑ 60.72%
Net Profit Margin
14.52%
↑ 14.52%
ROE
1022.77%
↑ 1022.77%
ROIC
44.57%
↑ 44.57%
Colgate-Palmolive Company (CL) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Colgate-Palmolive Company stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $4.91B | $4.95B | $5.03B | $5.06B |
| Cost of Revenue | $1.92B | $1.96B | $1.96B | $1.99B |
| Gross Profit | $2.99B | $2.98B | $3.07B | $3.07B |
| Gross Profit Ratio | $0.61 | $0.60 | $0.61 | $0.61 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.90B | $1.90B | $1.98B | $1.91B |
| Operating Expenses | $1.90B | $1.92B | $2.009B | $1.91B |
| Total Costs & Expenses | $3.82B | $3.88B | $3.97B | $3.90B |
| Interest Income | $15.00M | $68.00M | $0.00 | $0.00 |
| Interest Expense | $66.00M | $118.00M | $56.00M | $60.00M |
| Depreciation & Amortization | $0.00 | $148.00M | $150.00M | $157.00M |
| EBITDA | $1.08B | $1.19B | $1.22B | $1.25B |
| EBITDA Ratio | $0.22 | $0.24 | $0.24 | $0.25 |
| Operating Income | $1.08B | $1.06B | $1.06B | $1.16B |
| Operating Income Ratio | $0.22 | $0.21 | $0.21 | $0.23 |
| Other Income/Expenses (Net) | -$123.00M | -$70.00M | -$79.00M | -$82.00M |
| Income Before Tax | $953.00M | $993.00M | $986.00M | $1.01B |
| Income Before Tax Ratio | $0.19 | $0.20 | $0.20 | $0.20 |
| Income Tax Expense | $227.00M | $214.00M | $210.00M | $243.00M |
| Net Income | $690.00M | $739.00M | $737.00M | $731.00M |
| Net Income Ratio | $0.14 | $0.15 | $0.15 | $0.14 |
| EPS | $0.85 | $0.90 | $0.90 | $0.89 |
| Diluted EPS | $0.85 | $0.90 | $0.90 | $0.89 |
| Weighted Avg Shares Outstanding | $0.00 | $817.70M | $817.70M | $819.70M |
| Weighted Avg Shares Outstanding (Diluted) | $0.00 | $822.50M | $822.50M | $823.70M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan